Zobrazeno 1 - 10 of 73 pro vyhledávání: '"Yasuyuki NISHIYAMA"'
1
Akademický článek
Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study.
Autor: Rumiko Tashima, Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama, Yasuhiro Okumura, Masahiro Nakano, Mamiko Fujisue, Yasuo Toyozumi, Nobuyuki Arima
Publikováno v: PLoS ONE, Vol 10, Iss 7, p e0119565 (2015)
The Ki-67 index is an important biomarker for indicating the proliferation of cancer cells and is considered to be an effective prognostic factor for breast cancer. However, a standard cut-off point for the Ki-67 index has not yet been established. T
Externí odkaz: https://doaj.org/article/8e79225136314f1ca8568965674e76a5
Zobrazit plný text záznamu
3
Abstract P2-09-32: Ki-67 index value and progesterone receptor status predict prognosis and suitable treatment in node-negative breast cancer patients with estrogen receptor positive and HER2 negative tumors
Autor: Nobuyuki Arima, Yasuo Toyozumi, Tomofumi Osako, Mamiko Fujisue, Yasuhiro Okumura, Yasuyuki Nishiyama, Reiki Nishimura
Publikováno v: Cancer Research. 78:P2-09
Background: Breast cancer is no longer a single disease with high molecular heterogeneity. Gene profiling has identified at least 4 subtypes: Luminal A, Luminal B, HER2-enriched and basal-like breast cancer. Moreover, immunohistochemistry (IHC) class
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::75cc62d6125421fd3928365f153f64b2
https://doi.org/10.1158/1538-7445.sabcs17-p2-09-32
Zobrazit plný text záznamu
5
Abstract P4-09-26: The difference between metachronous and synchronous bilateral breast cancer in terms of clinical features and biology
Autor: K Murakami, Mamiko Fujisue, Tomofumi Osako, Yasuo Toyozumi, Yasuhiro Okumura, Nobuyuki Arima, Reiki Nishimura, Yasuyuki Nishiyama
Publikováno v: Cancer Research. 76:P4-09
Introduction The recent diagnostic modality such as MRI can diagnose a tiny breast lesion even in healthy contralateral breasts. Recently, the rate of contralateral prophylactic mastectomy (CPM) is on the rise in the United States. In Japan, the CPM
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4424d75feb901a5948061f9e9019b45f
https://doi.org/10.1158/1538-7445.sabcs15-p4-09-26
Zobrazit plný text záznamu
6
Electric Resistance Measurements of Anodic Oxide Films on Titanium and Zirconium
Autor: Shinji Fujimoto, Yasuyuki Nishiyama, Hiroaki Tsuchiya
Publikováno v: ECS Meeting Abstracts. :1156-1156
Valve metals such as titanium and zirconium can be subjected to anodization to form a thick compact oxide film in fluoride-free electrolytes at room temperature, and the thickness and structure of the film can be controlled by anodization conditions.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2f5a0ef410d13c5992a45a54e9033f9d
https://doi.org/10.1149/ma2020-0281156mtgabs
Zobrazit plný text záznamu
7
Ki‑67 index value and progesterone receptor status can predict prognosis and suitable treatment in node‑negative breast cancer patients with estrogen receptor‑positive and HER2‑negative tumors
Autor: Tomofumi Osako, Yasuo Toyozumi, Nobuyuki Arima, Mamiko Fujisue, Yasuhiro Okumura, Masahiro Nakano, Yasuyuki Nishiyama, Reiki Nishimura
Publikováno v: Oncology Letters.
Gene profiling has identified at least 4 breast cancer subtypes, including Luminal A, Luminal B, HER2-enriched and basal-like, and immunohistochemistry is used as a guide to determine these subtypes. In the present study, patients with ER-positive, H
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::988f3c0fc214fabababc8cd82ae4628d
https://doi.org/10.3892/ol.2018.9633
Zobrazit plný text záznamu
8
A Comparison of the Hot Spot and the Average Cancer Cell Counting Methods and the Optimal Cutoff Point of the Ki-67 Index for Luminal Type Breast Cancer
Autor: Mamiko Fujisue, Yasuo Toyozumi, Tomofumi Osako, Reiki Nishimura, Nobuyuki Arima, Masahiro Nakano, Yasuyuki Nishiyama, Yasuhiro Okumura, Rumiko Tashima
Publikováno v: Oncology. 90:43-50
Objective: In this case-control study, we investigated the most suitable cell counting area and the optimal cutoff point of the Ki-67 index. Methods: Thirty recurrent cases were selected among hormone receptor (HR)-positive/HER2-negative breast cance
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d042a6c034715e4d1e226ffc438aaf5c
https://doi.org/10.1159/000441525
Zobrazit plný text záznamu
9
Pertuzumab for the treatment of patients with human epidermal growth factor receptor 2-positive breast cancer in Japan
Autor: Mamiko Fujisue, Yasuyuki Nishiyama, Tomofumi Osako, Reiki Nishimura
Publikováno v: Molecular and Clinical Oncology
Pertuzumab, a novel anti-human epidermal growth factor receptor 2 (HER2) agent, is effective for metastatic HER2-positive breast cancer when used in combination with taxane and trastuzumab. The aim of the present study was to describe the use of pert
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4697bc000eb96d88013e1f9c7cfe88ff
https://doi.org/10.3892/mco.2015.640
Zobrazit plný text záznamu
10
Abstract P3-06-40: Prognostic impact of PgR and Ki-67 expression in ER-positive and HER2-negative breast cancer patients
Autor: Tomofumi Osako, Yasuhiro Okumura, Nobuyuki Arima, Yasuyuki Nishiyama, Reiki Nishimura
Publikováno v: Cancer Research. 75:P3-06
Background: The 13th St Gallen International Breast Cancer Conference (2013) proposed that conventional and new clinico-pathological factors provided a surrogate subtype classification. Moderate or strong expression of PgR has been proposed as an add
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0d34573a3cb6a23b5b367dfbe45b3cc4
https://doi.org/10.1158/1538-7445.sabcs14-p3-06-40
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje